Phillip James Consulting Co.
Source: SEC Form 13F · as of Mar 2026Phillip James Consulting Co. holds 19 biotech & pharma companies tracked by BioSniper, totaling $1.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$1.1M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,559 | $424K |
| JNJJOHNSON & JOHNSON | 966 | $236K |
| LLYELI LILLY & Co | 207 | $190K |
| MRKMerck & Co., Inc. | 792 | $95K |
| ABBVAbbVie Inc. | 185 | $40K |
| ABTABBOTT LABORATORIES | 168 | $17K |
| BMYBRISTOL MYERS SQUIBB CO | 285 | $17K |
| PFEPFIZER INC | 581 | $16K |
| CAHCardinal Health Inc. | 69 | $14K |
| PMPhilip Morris International Inc | 14 | $2K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2 | $1K |
| GILDGILEAD SCIENCES, INC. | 10 | $1K |
| GMOptec International, Inc. | 16 | $1K |
| IDXXIDEXX LABORATORIES INC /DE | 1 | $1K |
| RGENREPLIGEN CORP | 4 | $1K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2 | $1K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 3 | $1K |
| AMGNAMGEN INC | 5 | $1K |
| BIIBBIOGEN INC. | 4 | $1K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.